677-21848-21389
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2021-08-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-10
Registered in v-safe
-
2021-08-10
Dose 1 — Pfizer-BioNTech
- 2021-08-10
- 2021-08-11
- 2021-08-12
- 2021-08-14
- 2021-08-15
- 2021-08-16
- 2021-08-17
- 2021-08-24
-
2021-08-31
Dose 2 — Pfizer-BioNTech
-
2021-09-14
Survey response — day 14, dose 2MedDRA: Nasal congestion, Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Runny nose, nasal congestion, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-09-21
- 2021-09-28
- 2021-10-05
- 2021-10-12
- 2021-12-02
- 2022-03-01
- 2022-08-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-10 | Pfizer-BioNTech | No |
| 2 | 2021-08-31 | Pfizer-BioNTech | No |
Free text
Release 9 — day 14, dose 2
Symptoms: Runny nose, nasal congestion, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release